venBio Partners LLC
Portfolio value QoQ: +85.1% 13F does not disclose cash
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 1.01% Est. buys $182,915,296 · sells $4,040,780
Median holding: 5.0 quarters Tracked Q1 2025–Q2 2026 · 70.0% still held
Performance vs S&P 500
Annualized: +124.4% · S&P 500: +28.7%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Sector breakdown
Full portfolio 7 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| PHVS | $160,569,809 | 30.92% | 4,643,430 | $29,509,471 | Up ×1 | ||
| Unknown issuer (CUSIP: 698955101) | $144,149,497 | 27.75% | 5,266,697 | Up ×1 | |||
| ALMS | $127,429,401 | 24.53% | 4,528,408 | $27,668,573 | |||
| ACHV | $38,623,122 | 7.44% | 5,914,720 | Up ×1 | |||
| ALXO | $26,671,201 | 5.14% | 12,884,638 | $837,502 | |||
| HRMY | $17,192,584 | 3.31% | 472,194 | $3,490,260 | Down ×1 | ||
| LYEL | $4,744,643 | 0.91% | 337,697 | $-2,029,559 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: 698955101) | $144,149,497 | 5,266,697 | 27.75% |
| ACHV | $38,623,122 | 5,914,720 | 7.44% |
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.